Vaxart, Inc. (VXRT) income statement
VXRTOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48+0.02 (+5.04%)
Close on Oct 19, 2026Market cap $115.15MP/E 3.2Yield –
Vaxart, Inc. financial ratios
See a number that looks wrong?